Cullinan Therapeutics Stock (NASDAQ: CGEM) stock price, news, charts, stock research, profile.
You can purchase shares of Cullinan Therapeutics (NASDAQ:CGEM) through any online brokerage.
There are no as such competitors for Cullinan Therapeutics.
Cullinan Therapeutics has a consensus price target of $29.88.
The stock price for Cullinan Therapeutics (NASDAQ: CGEM) is $10.98 last updated January 30, 2025 at 4:00 PM EST.
There are no upcoming dividends for Cullinan Therapeutics.
Cullinan Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.
There is no upcoming split for Cullinan Therapeutics.
Cullinan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.